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Douglas M. Ziedonis, M.D., M.P.H.; Joseph Guydish, Ph.D., M.P.H.; Jill Williams, M.D.; 
Marc Steinberg, Ph.D.; and Jonathan Foulds, Ph.D. 
Despite the high prevalence of tobacco use among people with substance use disorders, tobacco 
dependence is often overlooked in addiction treatment programs. Several studies and a meta-analytic 
review have concluded that patients who receive tobacco dependence treatment during addiction 
treatment have better overall substance abuse treatment outcomes compared with those who do not. 
Barriers that contribute to the lack of attention given to this important problem include staff attitudes 
about and use of tobacco, lack of adequate staff training to address tobacco use, unfounded fears 
among treatment staff and administration regarding tobacco policies, and limited tobacco dependence 
treatment resources. Specific clinical-, program-, and system-level changes are recommended to fully 
address the problem of tobacco use among alcohol and other drug abuse patients. KEY WORDS: Alcohol 
and tobacco; alcohol, tobacco, and other drug (ATOD) use, abuse, dependence; addiction care; tobacco 
dependence; smoking; secondhand smoke; nicotine; nicotine replacement; tobacco dependence 
screening; tobacco dependence treatment; treatment facility-based prevention; co-treatment; treatment 
issues; treatment barriers; treatment provider characteristics; treatment staff; staff training; AODD 
counselor; client counselor interaction; smoking cessation; Tobacco Dependence Program at the 
University of Medicine and Dentistry of New Jersey 
Tobacco dependence is one of the most common substance use disorders and a leading cause of 
morbidity and mortality in addiction 
treatment programs (American Psychiatric 
Association [APA] 2006; Ziedonis and 
Williams 2003). Not surprisingly, people 
who successfully maintain abstinence 
from alcohol and other drugs often will 
prematurely die from tobacco-caused 
diseases such as coronary artery disease, 
chronic obstructive pulmonary disease, 
lung cancer, etc. (Hurt et al. 1996). 
Multiple biological, psychological, and 
social factors account for the high co­
occurrence of alcohol and tobacco 
dependence, including genetic evidence 
showing that people with genetic vulnera­
bility to one disorder also are vulnerable 
to the other. The common genetic vul­
nerability may be located on chromo­
some 2 (Bierut et al. 2004; True et al. 
1999; See also the article by Grucza and 
Bierut in this issue). 
Despite the existence of effective, 
evidence-based nicotine dependence 
treatments, tobacco dependence is com­
monly ignored in addiction treatment 
programs. Why has tobacco dependence 
treatment not been routinely integrated 
into addiction treatment programs? 
What are the barriers? Interestingly, 100 
years ago the treatment of alcohol, opi­
ates, and cocaine problems included 
treating tobacco dependence (Hoffman 
and Slade 1993). Addiction was perceived 
as a unitary problem, and the use of either 
the primary substance or any other sub­
stance use was considered a potential 
trigger for the primary addiction. What 
led to the decision to defer to primary 
care for the treatment of tobacco 
dependence? This paper will attempt to 
answer these questions and to make rec­
ommendations for addressing tobacco 
use in addiction treatment programs. 
Integrating Tobacco 
Dependence Treatment 
at the Clinical, Program, 
and System Levels 
Addiction treatment professionals 
eventually recognized that co-occurring 
mental illness and addiction needed to 
be addressed in the context of addic-
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tion treatment programs. Likewise, mem­
bers of this field are beginning to recog­
nize that there also is a need to inte­
grate tobacco dependence treatment 
across the continuum of substance abuse 
treatment and prevention services. 
Improved health services interventions 
for tobacco dependence are needed at 
the clinical, program, and system levels 
(Stuyt et al. 2003). Clinical-level 
change requires better screening and 
assessment of nicotine dependence and 
the inclusion of tobacco dependence in 
the treatment plan. Staff training is 
necessary and an important first step to 
address attitudes, skills, and knowledge. 
Staff who traditionally treated “alcohol 
dependence only” have adapted their 
skills and knowledge to treat other co­
occurring substance use disorders such 
as marijuana or cocaine addiction. A 
similar transformation could occur for 
co-occurring alcohol and tobacco 
dependence. In addition to staff train-
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try to help a patient quit smoking–– 
sometimes as a result of their own guilt 
and shame about their own smoking. 
In the authors’ clinical work and role as 
trainers to other professionals, staff 
members who smoke often support 
smoking with their patients as their 
way to promote a better “therapeutic 
alliance.” Although spending nontreat­
ment time with patients can be positive 
(such as taking walks, sharing meals, 
etc.), engaging in addictive behaviors 
with a patient is inappropriate and 
unhelpful for recovery. Smoking with 
patients also normalizes tobacco addic­
tion and even enhances its value as a 
therapeutic event. An early first step 
in program change can include policies 
to restrict staff smoking with patients. 
This policy change promotes the addic­
tion professional’s role in promoting 
health and recovery instead of reinforc­
ing the use of substances to manage 
feelings and cope with stress. 
Providing tobacco-dependent staff 
with the resources, support, and encour­
agement for their own tobacco depen­
dence treatment is important for their 
health, their family’s health, and the 
patient’s health. In addition, employers 
have recognized the value of having 
nonsmoking staff. Health care costs 
are 40 percent higher for smokers than 
nonsmokers. In addition, employees 
who smoke spend about 18 days a year 
on smoking breaks, cost a company 
drug plan about twice as much, and 
are absent from work 26 percent more 
often than nonsmokers (Tobacco Free 
Oregon 2003). More employers are 
recognizing that tobacco use in the 
workforce reduces productivity and 
increases costs, and, as a result, some 
employers have changed their hiring 
practices and policies regarding 
employee smoking. More employers 
are helping staff who smoke to quit but 
also are only hiring nonsmoking staff. 
Lack of Training 
Staff members in addiction treatment 
settings often receive little or no train­
ing in treating tobacco dependence. 
Fortunately, addiction counselors know 
how to treat other addictions, and the 
learning curve is quick and often very 
ing, other program-level interventions 
include developing models that integrate 
the treatment of alcohol and tobacco 
dependence, staff training on assessing 
and treating tobacco dependence, and 
continuous quality improvement on this 
topic. Broader system-level interven­
tions include increasing collaboration 
between health and behavioral health 
providers, developing policy changes to 
promote addressing tobacco, and pro­
viding financial support for tobacco 
dependence treatment. 
This article reviews commonly per­
ceived barriers to addressing tobacco and 
health services interventions that can help 
addiction treatment programs better 
recognize and treat tobacco dependence. 
Barriers 
In addition to program culture and 
financial barriers to treating tobacco 
dependence, staff attitudes, skills, and 
knowledge all influence the lack of 
attention given to tobacco in addiction 
treatment programs. Staff attitudes set 
the tone as to whether tobacco depen­
dence will be addressed; tobacco-
dependent staff often are the most 
resistant to change (Bobo and Davis 
1993; Asher et al. 2003; Williams et al. 
2005; Hurt et al. 1995). Treatment 
wisdom discourages major life changes 
during early recovery for fear of relapse, 
and the treatment culture has accepted 
that “quitting tobacco” would be a 
major life change––although quitting 
other substances simultaneously is not 
(Sussman 2002; Joseph et al. 2002). 
Staff Attitudes and Tobacco Use 
About 30 to 40 percent of addiction 
treatment staff in community-based 
programs are tobacco dependent 
(Bernstein and Stoduto 1999) com­
pared with about 60 to 95 percent of 
patients (APA 2006; Lasser et al. 2000; 
Richter et al. 2004); 22 percent of the 
general population (Centers for Disease 
Control and Prevention [CDC] 2005); 
and 3 to 5 percent of physicians, den­
tists, and dental hygienists (Goldstein 
et al. 1998; APA 2006). Staff members 
who smoke most likely are not going to 
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Tobacco Dependence Training Resources 
for Addiction Treatment Staff 
University of Massachusetts Medical School, Center for Tobacco Prevention and Control 
The Center is actively engaged in a wide range of tobacco-related research, clinical treatment services, technical 

assistance, and professional education programs. Available at: www.umassmed.edu/behavmed/tobacco
 
University of Medicine and Dentistry of New Jersey (UMDNJ) Tobacco Dependence Program 
The UMDNJ provides training programs on tobacco dependence (including a 5-day comprehensive training program) as 
well as program consultation, technical assistance, research, and clinical service. Resources on their Web site include 
information on how to obtain their “Drug Free is Nicotine Free” manual for program change. Available at: 
www.tobaccoprogram.org 
Mayo Clinic Nicotine Dependence Center Education Program 
This is an intensive, 5-day course focusing on the skills needed to effectively treat tobacco dependence. Available at: 
http://mayoresearch.mayo.edu/mayo/research/ndc_education/tts_certification.cfm 
Association for the Treatment of Tobacco Use and Dependence (ATTUD) 
The ATTUD is dedicated to the promotion of and increased access to evidence-based tobacco treatment and has 
developed standards for competencies for tobacco treatment specialists. Many of the national training centers follow 
these competencies. The ATTUD standards are available at: www.attud.org 
ACT Center for Tobacco Treatment, Education, and Research of the University of Mississippi 
The ACT Center, a program of the University of Mississippi Medical Center School of Dentistry, provides training, 
education, treatment, and research, including a comprehensive tobacco treatment specialist training program. Available 
at: http://actcenter.umc.edu/ 
University of Wisconsin Medical School, Center for Tobacco Research and Intervention (UW-CTRI) 
The UW-CTRI program provides extensive training and technical assistance to help put tobacco cessation research 
into practice. Available at: www.ctri.wisc.edu and www.medscape.com/viewprogram/3607 (CME online) 
The Addiction Technology Transfer Center of New England 
Funded by the Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment, 
the Addiction Technology Transfer Center of New England is offering an online course on the cessation of tobacco 
use: “Tobacco Cessation Treatment: Best Practices.” Available at: www.attc-ne.org/education/courses/ann262.html 
Center for Substance Abuse Treatment 
Substance Abuse Treatment for Persons With Co-Occurring Disorders. Treatment Improvement Protocol (TIP) Series 42. 
Rockville, MD: Department of Health and Human Services publication no. (SMA) 05-3992. Substance Abuse and 
Mental Health Services Administration, 2005. This includes several lengthy sections on assessing and treating 
tobacco dependence. Available at: www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat5.chapter.74073 
U.S. Department of Health and Human Services 
The health consequences of involuntary exposure to tobacco smoke: A report of the Surgeon General, 2006.
 
Available at: www.surgeongeneral.gov/library/secondhandsmoke/
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rewarding when applied to tobacco. 
The lack of training for most staff 
members reflects the field’s blinders to 
this topic––but this is changing. The 
National Association of Alcoholism 
and Drug Abuse Counselors (NAADAC) 
now offers a Tobacco Addiction 
Specialist credentialing program and 
has a policy that “advocates and sup­
ports the development of policies and 
programs that promote the prevention 
and treatment of nicotine dependence 
on par with alcoholism and drug 
dependence” (NAADAC 2006). Some 
States offer “Tobacco Dependence 
Specialist Added Qualifications” to their 
certified alcohol and drug counselor 
certification programs, and many States 
now require mandatory tobacco training 
as part of both initial and recertification 
for credentialed addiction counselors. 
Several national training centers provide 
intensive face-to-face or online training 
and other resources (see the Textbox on 
page 230). 
Providing staff training enhances 
skills and knowledge––and also changes 
attitudes. With appropriate skills and 
knowledge, staff members often recog-
nize that part of their role is to treat 
tobacco dependence––and that this is 
not just primary care’s responsibility. 
They can better appreciate that tobacco 
use must be addressed because of the 
increased morbidity and mortality 
among their patients. In addition, envi­
ronmental tobacco smoke (ETS) affects 
both smokers and nonsmokers. Children, 
people with existing cardiac disease, 
and older adults are particularly vulner­
able to the health consequences of ETS. 
Many staff members are surprised to 
learn that tobacco use is the number 
one preventable cause of death in the 
United States (CDC 2001) (see Figure). 
More addiction treatment programs and 
clinicians are recognizing that address­
ing tobacco dependence is important 
for promoting wellness and recovery. 
All smokers should be encouraged to 
seek tobacco dependence treatment at 
some point in their recovery, and 
addiction treatment staff can readily 
learn to use the evidence-based psy­
chosocial treatments and integrate their 
use with appropriate medications (includ­
ing several over-the-counter options). 
System-level reminders to trigger staff 
to screen, assess, and treat tobacco 
dependence routinely are needed to 
ensure that tobacco dependence treat­
ment skills are utilized (Ziedonis et al. 
2006). Strategies for treating patients at 
all levels of motivation to quit are 
important. Effective brief interventions 
for addressing tobacco dependence in 
less motivated smokers have been eval­
uated (Steinberg et al. 2004) and may 
be useful for addressing tobacco in 
addiction treatment populations. 
Comparative causes of annual deaths in the United States. Tobacco use is the 
number one preventable cause of death in the United States. 
SOURCE: Centers for Disease Control and Prevention (CDC), 2001. Available at: 
www.cdc.gov/tobacco/research_data/health_consequences/andths.htm 
-
-
Clinical Lore 
Training staff members to treat tobacco 
dependence also helps change the treat­
ment culture by correcting many of the 
misconceptions or “clinical lore” about 
tobacco––such as “tobacco is not a real 
drug,” “it’s too hard to address all the 
substances together,” and “quitting 
tobacco will definitely worsen other 
substance recovery.” Clearly, tobacco 
is both addictive and deadly––even if 
the serious health consequences are 
not immediate and do not disrupt the 
patient’s life as dramatically as other 
substances with regard to legal, employ­
ment, and family problems. Patients 
are apt to minimize the impact of all 
their drug use, especially when the 
consequences are not immediate and 
visible. Staff members know how to 
address this type of rationalization and 
denial regarding other substances. For 
programs that continue to allow smok­
ing at breaks, there are opportunities to 
observe patients’ regressive behaviors 
during breaks––when many behaviors 
can shift back to a “bar scene.” Staff 
members can effectively discuss these 
changes during treatment, as they may 
mirror prerelapse risk behaviors after 
discharge. 
Some staff members believe that 
quitting tobacco would be too stressful 
during treatment. Of course, some 
patients who smoke will not object, 
and some patients may also believe that 
they do not have to stop marijuana 
when they quit alcohol or stop alcohol 
use when their primary drug is heroin. 
Patients may express their own con­
cerns that the urge to smoke will be 
intolerable, withdrawal will be very dif­
ficult, quitting will affect their primary 
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recovery, and they may actually need 
cigarettes to help them cope with stress 
(Asher et al. 2003). In fact, evidence 
suggests that the opposite can occur–– 
that tobacco use can harm, rather than 
enhance, recovery from other substance 
use by its ability to trigger other substance 
use (Williams et al. 2005; APA 2006). 
Another potential barrier is that 
some staff may believe that their patients 
are just not interested in quitting 
smoking. As a result, the staff will not 
discuss the issue of tobacco dependence 
and quitting. However, many substance 
abusers are interested in quitting smok­
ing as part of recovery (Ziedonis and 
Williams 2003; APA 2006). Although 
more than half of patients who smoke 
believe that quitting smoking will be the 
hardest addiction for them to address 
(Kozlowski et al. 1989), there is evi­
dence that tobacco addiction can be 
treated successfully in addiction treat­
ment programs, both immediately and 
later in the recovery process. In a recent 
meta-analytic review of randomized tri­
als of smoking cessation in substance 
abuse settings, Prochaska and colleagues 
(2004) concluded that patients engag­
ing in tobacco dependence treatment 
had better overall substance abuse 
treatment outcomes at 6 months after 
treatment compared with those who 
did not engage in tobacco dependence 
treatment. The exact best timing for an 
individual patient is less clear (Joseph 
et al. 2004); however, the key is to 
assess and make a plan to treat tobacco 
dependence at some point during treat­
ment and/or recovery. 
Steps for Addressing Tobacco Within Addiction
 
Treatment Programs
 
1. 	 Acknowledge the challenge to address the barriers and integrate the 
solutions 
2. 	 Establish a leadership group and make a commitment to change 
3. 	 Create a change plan and realistic implementation timeline 
4.	 Start with easy program and system changes, including tobacco policies  
5.	 Conduct staff training 
6.	 Assess and document in charts nicotine use, dependence, and prior 
treatments 
7.	 Incorporate tobacco issues into all patient education curriculums 
8. 	 Provide medications for nicotine dependence treatment    
9. 	 Provide treatment and recovery assistance for interested nicotine-
dependent staff 
10. Integrate motivation-based treatments throughout the program  
11. Establish ongoing communication about system changes with 12-Step 
recovery groups, professional colleagues, and referral sources  
12. Consider additional policies addressing tobacco, including smoke-free 
grounds 
NOTE: Adapted from Order-Connors B. Smoke screen. Professional Counselor 11(6):15–52, 1996. 
Smoke-Free Buildings and 
Resistance to Smoke-Free Grounds 
Secondhand tobacco smoke poses a 
real health risk to everyone exposed to 
the smoke, and the issue is well addressed 
in the recent Surgeon General’s Report 
on Secondhand Smoke (U.S. Department 
of Health and Human Services 2006). 
The Textbox on page 233 lists the key 
findings from this report. The need to 
provide clean indoor air has resulted in 
policy changes to require smoke-free 
buildings in many workplaces and 
public settings, including health care 
facilities. Although there was initial 
resistance to smoke-free buildings by 
some addiction treatment staff, State 
laws and requirements set by the Joint 
Commission on Accreditation of 
Healthcare Organizations have changed 
the norm to smoke-free buildings for 
treatment. In addition to smoke-free 
buildings, some inpatient workplaces 
(including addiction treatment programs) 
have taken an additional step toward 
addressing tobacco by implementing 
“smoke-free grounds.” This step means 
that tobacco smoking is not allowed 
anywhere on the grounds of the addic­
tion treatment program, rather than just 
being prohibited in the buildings. Having 
entirely tobacco-free grounds is an addi­
tional policy change that some States 
have now mandated for their treatment 
programs (see Sidebar on pp. 236– 240). 
Staff members who smoke often ini­
tially oppose the “smoke-free grounds” 
level of program change. Program lead­
ers, administrators, or staff members 
also may have concerns that patients 
will act out, have worse withdrawal, 
leave against medical advice (AMA), or 
seek treatment at competing programs 
that allow smoking. Contrary to expec­
tations, treatment programs with 
smoke-free grounds often report less 
acting out, less haggling about smoke 
breaks/number of cigarettes allowed, 
less coercion of smokers by either peers 
or staff, no increase in the AMA dis­
charge rate, increased likelihood of 
completed treatment, and an increase 
in the number of patients seeking treat­
ment (APA 2006; Williams et al. 2005; 
Hurt et al. 1995). 
Other cultural milieu barriers are 
subtle. Some programs still sell 
cigarettes with the profits contributing 
to one of the few “discretionary” funds 
to which these programs have access. 
The projected loss of these funds obvi­
ously contributes to administrative 
resistance to this change. Some addic­
tion treatment programs are housed 
within psychiatric care facilities with 
even less attention to tobacco use. 
Limited Treatment Resources 
Available treatment resources––especially 
coverage for tobacco dependence treat-
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ment medications––often are limited 
for tobacco-dependent staff and patients. 
This is especially problematic for patients 
who may have limited income and are 
underinsured or uninsured. In the gen­
eral population, psychosocial behav­
ioral therapy alone can be as effective 
as medications alone in the treatment 
of tobacco dependence (APA 2006). 
However, there is a much greater likeli­
hood of receiving only medications 
for tobacco dependence treatment. 
Integrating psychosocial tobacco 
dependence treatment into addictions 
treatment is an effective way to over­
come some of the financial issues. For 
example, psychosocial treatment inter­
ventions in addiction treatment programs 
commonly address multiple drugs for 
any individual because other drugs (includ­
ing tobacco) are triggers for the primary 
addiction. Integrating smoking cessation 
into routine addiction psychosocial 
treatment helps the primary addiction 
and does not require additional billing 
specific to tobacco dependence to the 
insurance company. As with other mul­
tiple addictions, charges for psychoso­
cial treatment are bundled so that pro­
grams address multiple problems under 
the primary substance use disorder. 
Many inpatient programs either do not 
have tobacco dependence treatment 
medications on their pharmacy formu­
lary or the options are very limited. 
Outpatient programs are more reliant 
on the patient’s health care benefits or 
willingness to pay out of pocket for 
these medications. Although the cost of 
over-the-counter nicotine replacement 
still is less than the cost of a carton of 
cigarettes, most patients still perceive 
that this out-of-pocket cost is too high 
and feel entitled to benefits covering 
those costs––even if they are not covered. 
Surgeon General’s Summary of the Effect of 
Secondhand Smoke 
1. Secondhand smoke causes premature death and disease in children and 
in adults who do not smoke. 
2. Children exposed to secondhand smoke are at an increased risk for 
sudden infant death syndrome (SIDS), acute respiratory infections, 
ear problems, and more severe asthma. Smoking by parents causes 
respiratory symptoms and slows lung growth in their children. 
3. Exposure of adults to secondhand smoke has immediate adverse effects on 
the cardiovascular system and causes coronary heart disease and lung 
cancer. 
4. The scientific evidence indicates that there is no risk-free level of 
exposure to secondhand smoke. 
5. Millions of Americans, both children and adults, are still exposed to 
secondhand smoke in their homes and workplaces despite substantial 
progress in tobacco control. 
6. Eliminating smoking in indoor spaces fully protects nonsmokers from 
exposure to secondhand smoke. Separating smokers from nonsmokers, 
cleaning the air, and ventilating buildings cannot eliminate exposures of 
nonsmokers to secondhand smoke. 
SOURCE: U.S. Department of Health and Human Services. The Health Consequences of Involuntary 
Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and 
Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, 
National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2006. 
Solutions 
Over the past 10 years, many addiction 
treatment agencies have begun to better 
address tobacco dependence and have 
benefited from program-level interven­
tions (Stuyt et al. 2003). One organiza­
tion doing these health services inter­
ventions—the University of Medicine 
and Dentistry of New Jersey (UMDNJ) 
Tobacco Dependence Program—has 
helped many addiction treatment pro­
grams incorporate evidence-based 
tobacco dependence treatment into 
ongoing practice. In some cases, these 
programs have adopted a “motivation­
based treatment” model to address 
tobacco dependence, which does not 
require abstinence by the patient, but 
all patients who are tobacco dependent 
get screened, assessed, and offered some 
type of treatment. 
Although addiction treatment pro­
grams use urine toxicology screens and 
breathalyzers to screen for alcohol and 
other drugs, most do not screen for 
tobacco use with a carbon monoxide 
(CO) meter. The CO meter is a good 
measure of tobacco smoking exposure 
and can be used as an effective tool to 
motivate patients to seek tobacco depen­
dence treatment (Steinberg et al. 2004). 
Education and other motivational 
enhancement interventions can help 
less motivated patients to incrementally 
increase their commitment to quit. For 
example, information about health 
risks, wellness interventions (stress 
management, nutrition, and exercise), 
Stage II Recovery, available medication 
and other treatments, local and online 
Nicotine Anonymous meetings, and 
other community treatment resources 
(e.g., State-supported Internet sites and 
telephone quit lines) can immediately 
help motivate some individuals. Others 
may save this information for a later 
quit attempt. More motivated patients 
can aim for tobacco abstinence and be 
effectively treated when psychosocial 
and medication treatments are blended 
into the “treatment as usual.” Program-
level interventions include staff train­
ing, policy changes, and, in some cases, 
establishing smoke-free grounds. 
An initial health service research 
study has found that the UMDNJ pro­
gram intervention can be effective in 
addressing tobacco dependence at the 
residential treatment program level, 
and another more rigorous health ser­
vices study funded by the National 
Institute on Drug Abuse (NIDA) cur­
rently is underway to study this 
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approach in the context of three com­
munity-based treatment programs 
within the NIDA Clinical Trial 
Network. The UMDNJ Tobacco 
Dependence Program co-leads this 
project and provides consultation and 
training to the programs. The consulta­
tion follows the steps outlined in the 
Textbox on page 232. 
Developing a leadership team with a 
game plan is a necessary first phase of 
the program intervention. Through 
that process the organization’s “motiva­
tional level” for addressing tobacco can 
be better determined. Meaningful 
change requires local champions of the 
change process. Resources of time and 
money are needed. Paradigm shifts are 
required, and staff training is essential. 
Because tobacco dependence is insidious 
in most addiction treatment programs, 
the leadership team should include rep­
resentatives from the whole organiza­
tion (i.e., administration, staff, union, 
housekeeping, security, grounds, etc.). 
Some system changes include modify­
ing standard intake forms to include a 
comprehensive tobacco dependence 
assessment, including tobacco on the 
treatment planning forms, providing 
patient education literature, posting 
pro-wellness posters and no-smoking 
signs, and starting local Nicotine 
Anonymous groups. Other changes can 
include developing policies specific to 
tobacco use, labeling smoker’s charts, 
changing the name of “smoke breaks” to 
just “breaks,” not allowing staff members 
to smoke with patients, and providing 
nicotine replacement therapies or other 
Food and Drug Administration–approved 
medication for smokers on the inpa­
tient units and possibly at other levels 
of care. 
When implementing tobacco-
related policy changes, it is helpful to 
ensure that such changes are not solely 
perceived as losses (e.g., we have all just 
lost our right to smoke). It may be 
helpful to provide a pleasant alternative 
during the transition. Individual pro­
grams should come up with strategies 
that work for them. One program, for 
example, replaced smoke breaks with 
“popcorn breaks,” with the agency pro­
viding free popcorn. 
Tobacco-dependent patients should 
have the resources available (including 
trained staff ) to help them quit, and 
patients and staff members who do not 
smoke should not be exposed to the 
toxins of ETS. There are clear barriers 
to addressing tobacco use and depen­
dence, but there also are effective ways 
to address these barriers and promote 
the integration of evidence-based tobacco 
dependence treatment into addiction 
treatment programs. 
The addiction treatment commu­
nity as a whole now has an opportunity 
to denormalize tobacco use for the field 
by tailoring traditional tobacco control 
strategies to the unique issues of the 
addiction treatment and recovery com­
munity. Denormalization of tobacco 
use includes making smoking behavior 
not the norm and providing education 
about the health risks of tobacco prod­
ucts and the activities of the tobacco 
industry (e.g., Truth Campaign [Thrasher 
et al 2004]). 
Although tobacco control strategies 
have effectively denormalized tobacco 
use in the general population (Hammond 
et al. 2006), these strategies have not 
targeted people with substance use dis­
orders. Tobacco control efforts within 
the addiction treatment and recovery 
community could help the field to 
recognize and manage tobacco depen­
dence as any other substance use disor­
der. Denormalization strategies in this 
setting would include assessing and 
treating tobacco dependence in treat­
ment programs, maintaining smoke-
free buildings and grounds, eliminating 
the sale and advertisement of tobacco 
products, improving understanding of 
the impact of smoking in the home on 
the children of people in recovery, and 
perhaps revealing how the tobacco 
industry may target people with other 
addictions (many of their ads link alco­
hol and tobacco). Targeted mass media 
campaigns have been effective in reduc­
ing tobacco use in the general popula­
tion, and opportunities exist to develop 
a media campaign for the addiction 
treatment and recovery community. 
The leaders of Alcoholics Anonymous, 
Bill W. and Dr. Bob, were both smok­
ers and died of tobacco-caused diseases 
before the health consequences and 
addictive nature of tobacco use were 
fully recognized. Undoing the “normal­
ization of tobacco” that has occurred 
within the addiction treatment and 12­
Step community for the last generation 
will need input from everyone involved 
in the treatment, prevention, and recov­
ery community. 
Conclusion 
Tobacco dependence is one of the most 
common addictions among people 
with alcohol and other drug addictions–– 
and a leading cause of morbidity and 
mortality in addiction treatment pro­
grams. Now is the time for addiction 
treatment programs to better address 
tobacco dependence at the clinical, 
program, and system levels. Many 
programs have been successful at doing 
so. Then there are real and perceived 
barriers to address, but as with recovery 
from any substance, the first step is 
to acknowledge the need for change. 
There are then many successful ways 
to begin and support that change.  ■ 
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